Digestive Diseases

 

Liver Transplantation for Solitary Hepatocellular Carcinoma Less than 3 cm in Diameter in Child A Cirrhosis

Poon R.T.P.

Author affiliations

Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

Keywords: Liver transplantationHepatocellular carcinomaCirrhosisResectionRadiofrequency ablation

Related Articles for ""
Dig Dis 2007;25:334–340
https://doi.org/10.1159/000106914

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: October 26, 2007
Issue release date: October 2007

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

Liver transplantation for hepatocellular carcinoma (HCC) is the treatment of choice for patients with unresectable tumors within the Milan criteria associated with Child B or C cirrhosis. Liver transplantation provides the best cure for both the HCC and the underlying cirrhosis. In recent years, some authors have advocated liver transplantation even for resectable early HCC associated with Child A cirrhosis, leading to a controversy of whether resection or transplantation should be the first-line therapy for patients with small HCC in Child A cirrhosis. Recent studies comparing liver resection and transplantation for early HCC demonstrated similar long-term survival of 60–70%, but liver transplantation is associated with a lower tumor recurrence rate. However, the current shortage of deceased donor liver grafts limits the applicability of liver transplantation for HCC. The use of live donor liver transplantation for patients with a small solitary HCC in Child A cirrhosis that is resectable may not be justified ethically because of the potential risk to the donors. Patients put on a transplantation waiting list run a significant risk of tumor progression and dropout, while liver resection is immediately applicable to all. Advocating primary liver transplantation for patients with early HCC associated with compensated cirrhosis will increase the waiting time for transplantation and further increases the chance of dropout. Resection first and salvage transplantation for recurrent tumors or liver failure is an alternative strategy that may reduce the use of liver grafts. However, the long-term survival result of such a strategy compared with primary liver transplantation remains unclear.

© 2007 S. Karger AG, Basel



Related Articles:

References

  1. El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001;5:87–107, vi.
    External Resources
  2. Poon RT, Fan ST, Lo CM, Ng IOL, Liu CL, Lam CM, Wong J: Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63–70.
    External Resources
  3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.
    External Resources
  4. Ng KK, Poon RT: Radiofrequency ablation for malignant liver tumor. Surg Oncol 2005;14:41–52.
    External Resources
  5. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE: Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401–407.
    External Resources
  6. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S: Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:53–58.
    External Resources
  7. Schwartz M: Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S268–S276.
    External Resources
  8. Llovet JM, Schwartz M, Mazzaferro V: Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181–200.
    External Resources
  9. Wu CC, Yeh DC, Lin MC, Liu PJ, P’Eng FK: Improving operative safety for cirrhotic liver resection. Br J Surg 2001;88:210–215.
    External Resources
  10. Poon RT, Lo CM, Fan ST, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004;240:698–708.
    External Resources
  11. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M: One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198–1206.
    External Resources
  12. Lang BH, Poon RT, Fan ST, Wong J: Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003;138:1207–1213.
    External Resources
  13. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J: Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol2000;18:1094–1101.
    External Resources
  14. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434–1440.
    External Resources
  15. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP: Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg2003;238:315–321.
    External Resources
  16. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J: Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580–587.
    External Resources
  17. Tanaka S, Noguchi N, Ochiai T, Kudo A, Nakamura N, Ito K, Kawamura T, Teramoto K, Arii S: Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: rationale for partial hepatectomy as first strategy. J Am Coll Surg 2007;204:1–6.
    External Resources
  18. Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I: Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl2005;11:1242–1251.
    External Resources
  19. Poon RT, Fan ST, Wong J: Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10–24.
    External Resources
  20. Poon RT, Fan ST, CM Lo, Liu CL, Wong J: Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma: long-term results of management and prognostic factors. Ann Surg 1999;229:216–222.
    External Resources
  21. Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, De Sio I, Brunello F, Solmi L, Caturelli E, Magnolfi F, Caremani M, Filice C: Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: a multicenter survey of evaluation practices and complication rates. Scan J Gastroenterol 1997;32:1168–1173.
    External Resources
  22. Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y, Terano A: Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 1991;68:1524–1530.
    External Resources
  23. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J: Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16:353–357.
    External Resources
  24. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151–1156.
    External Resources
  25. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L: Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206–1222.
    External Resources
  26. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST: Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 2004;139:281–287.
    External Resources
  27. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321–328.
    External Resources
  28. Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, Tong MJ, Amado RG, Busuttil RW: Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005;234:954–960.
    External Resources
  29. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L: Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005242:158–171.
    External Resources
  30. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129.
    External Resources
  31. De Baere T, Risse O, Kuoch V, et al: Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 2003;181:695–700.
    External Resources
  32. Poon RT, Ng KK, Lam CM, et al: Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004;11:281–289.
    External Resources
  33. Livraghi T, Lazzaroni S, Meloni F, Solbiati L: Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005;92:856–858.
    External Resources
  34. Lo CM, Fan ST, Liu CL, Lai CL, Wong J: Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 2003;75(suppl 3):S41–S44.
    External Resources
  35. Kotlyar DS, Campbell MS, Reddy KR: Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol 2006;101:1370–1378.
    External Resources
  36. Yao F, Bass NM, Nikolai B, Roberts JP: Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002;8:873–883.
    External Resources
  37. Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, Gores G: Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004;10:449–455.
    External Resources
  38. Pierie JP, Muzikansky A, Tanabe KK, Ott MJ: The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma. Ann Surg Oncol 2005;12:552–560.
    External Resources
  39. Yao FY, Bass NM, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl 2004;10:621–630.
    External Resources
  40. Lo CM, Fan ST, Liu CL, Chan SC, Wong J: The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004;10:440–447.
    External Resources
  41. Chan SC, Fan ST, Lo CM, Liu CL, Wong J: Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg 2007;245:110–117.
    External Resources
  42. Kulik L, Abecassis M: Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S277–S282.
    External Resources
  43. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J: Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007;94:78–86.
    External Resources
  44. Ravaioli M, Ercolani G, Cescon M, et al: Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004;10:1195–1202.
    External Resources
  45. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, Weber JC, Audet M, Doffoel M, Wolf P: Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003;9:513–520.
    External Resources
  46. Shabahang M, Franceschi D, Yamashiki N, Reddy R, Pappas PA, Aviles K, Flores S, Chaparro A, Levi JU, Sleeman D, Tzakis AG, Kato T, Levi DM, Livingstone AS: Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002;9:881–886.
    External Resources
  47. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007;245:51–58.
    External Resources
  48. Bechstein WO, Guckelberger O, Kling N, Rayes N, Tullius SG, Lobeck H, Vogl T, Jonas S, Neuhaus P: Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int 1998;11(suppl 1):S189–S192.
    External Resources
  49. Poon RT, Fan ST: Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl 2004;10:813–815.
    External Resources
  50. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382.
    External Resources
  51. Hu RH, Ho MC, Wu YM, Yu SC, Lee PH: Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Clin Transplant2005;19:175–180.
    External Resources
  52. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H: Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508–518.
    External Resources
  53. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel M, Sauvanet A, Farges O, Kianmanesh R: Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003;238:885–893.
    External Resources
  54. Poon RT, Fan ST: Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? Ann Surg 2004;240:925–928.
    External Resources
  55. Sala M, Fuster J, Llovet JM, Navasa M, Sole M, Varela M, Pons F, Rimola A, Garcia-Valdecasas JC, Bru C, Bruix J, Barcelona Clinic Liver Cancer (BCLC) Group: High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage transplantation. Liver Transpl 2004;10:1294–1300.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: October 26, 2007
Issue release date: October 2007

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2007, Vol.25, No. 4

October 2007

Article

Recommend This
TOP